Skandinaviska Enskilda Banken AB »

Denali Therapeutics shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.2M 348k 20.63
2023-06-30 $10M 348k 29.51
2023-03-31 $7.1M 307k 23.04
2022-12-31 $8.6M 309k 27.81
2022-09-30 $8.9M 291k 30.69
2022-06-30 $6.3M 213k 29.43
2022-03-31 $4.5M 139k 32.17
2021-12-31 $6.2M 139k 45.05
2021-09-30 $6.7M 132k 50.45
2021-06-30 $2.3M 30k 78.43
2021-03-31 $1.5M 26k 57.09
2020-12-31 $2.2M 26k 83.75